Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.

about

How much European prescribing physicians know about invasive fungal infections management?A complex game of hide and seek: the search for new antifungals Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

P2860

Q35131938-D122B8D1-48B5-40D5-86F1-A9B96C9D93F7 Q37344546-C70D9FD6-22A2-4C1B-ADFC-517F3EA8FB95 Q38681635-E13A20EC-1C23-4253-86FA-9560C9C11062

P2860

Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.

Item

http://www.wikidata.org/entity/Q38149163

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current pharmacological concep ...... eptic critically ill patients.

@en

type

Item

label

Current pharmacological concep ...... eptic critically ill patients.

@en

prefLabel

Current pharmacological concep ...... eptic critically ill patients.

@en

P1476

Current pharmacological concep ...... eptic critically ill patients.

@en

P2860

A drug-sensitive genetic network masks fungi from the immune system

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

Infective endocarditis in the U.S., 1998-2009: a nationwide study

The pathophysiology and treatment of sepsis

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

P304

989-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2013.836058

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Federico Pea

P577

2013-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24093543

http://www.w3.org/2001/XMLSchema#string

P921

sepsis

Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.

about

P2860

P2860

Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921